[Evaluation of rational lymph node dissection for abdominal neuroblastoma]

Area of Science:

• Oncology
• Surgical Oncology

Context:

• Neuroblastoma, a pediatric cancer, often requires complete tumor resection.
• Retroperitoneal neuroblastoma with nodal involvement presents surgical challenges.
• Activated carbon particles have been explored to enhance lymph node dissection accuracy.

Purpose:

• To evaluate the efficacy and safety of activated carbon-guided lymph node dissection in retroperitoneal neuroblastoma surgery.
• To assess outcomes in patients with varying stages of neuroblastoma, including those detected via mass screening.

Summary:

• A review of 22 patients with retroperitoneal neuroblastoma undergoing activated carbon-guided lymph node dissection was conducted.
• Fourteen patients with Stages I, II, and IV-S neuroblastoma achieved long-term survival with no evidence of disease.
• No local recurrence was observed, and complications were minimal across all patients.

Impact:

• Rational lymph node dissection using activated carbon particles is recommended for retroperitoneal neuroblastoma.
• This technique improves complete tumor resection rates and patient outcomes.
• The method is particularly beneficial for mass-screened populations and early-stage disease.